https://www.avient.com/sites/default/files/2025-03/CAI Solutions for Recycled Resins in E_E Applications Product Bulletin _A4.pdf
Cesa™ Unify™ A4R Polyolefin Compatibilizer
helps bring incompatible polymers like PP
and PE together by forming them into a
homogenous polymer mixture which increases
the mechanical properties of the recycled
polymer
https://www.avient.com/sites/default/files/2021-01/case-study-one-pager-gravi-tech-luxury-closures-english-and-spanish_0.pdf
https://www.polyone.com/products/engineered-polymer-formulations/eco-conscious-formulations/gravi-tech-density-modified
P R O D U C T O R L Í D E R D E
TA P O N E S PA R A B E B I DA S
A L C O H Ó L I C A S
T A P O N E S D E L U J O
• Se sustituye el metal al mismo tiempo que se ofrece
aspecto y sensación metálicos
• Personalización de densidad y color
• Procesamiento sencillo
• Cumplimiento con las normas de la FDA
• El metal se sustituye con un compuesto
plástico de densidad modificada para
mantener una percepción de alta calidad
• Se redujo al mínimo la aparición de
desportilladuras por el desgaste cotidiano,
que supera al metal porque permite hacer
coincidir el interior de la tapa con los
colores de revestimiento metalizado
• Permitió al cliente introducir sus tapones
de lujo en un nuevo segmento del mercado
Formulación de densidad modificada Gravi-
Tech™
REQUERIMIENTOS CLAVE
¿POR QUÉ AVIENT?
https://www.avient.com/sites/default/files/2021-05/avient-austria-gmbh-extract-may-10-2021.pdf
GESCHÄFTSFÜHRER/IN (handelsrechtlich)
F Anke Bergheim, geb. 03.06.1970
4 vertritt seit 10.03.2021 selbständig
G Christoph Palm, geb. 16.05.1963
4 vertritt seit 10.03.2021 selbständig
H Norbert Merklein, geb. 03.05.1964
4 vertritt seit 10.03.2021 selbständig
GESELLSCHAFTER/IN STAMMEINLAGE HIERAUF GELEISTET
B Aviant Switzerland GmbH
1 .......................
EUR 35.000
-------------------------------------------------------
Summen: EUR 35.000 EUR 35.000
--- PERSONEN ----------------------------------------------------------------
4 B Aviant Switzerland GmbH
1 (Handelsregister des Kantons Basel-Landschaft
CHE-112.279.714)
Sitz in Muttenz
Aktiengesellschaft
1 Rothausstraße 61
CHE-4132 Muttenz
4 F Anke Bergheim, geb. 03.06.1970
4 Clemensstraße 14
DEU-80803 München
4 G Christoph Palm, geb. 16.05.1963
4 Gruuss-Strooss 35
LUX-9991 Weiswampach
4 H Norbert Merklein, geb. 03.05.1964
4 Schiffackerweg 2
CHE-4310 Rheinfelden
-------------------- VOLLZUGSÜBERSICHT ---------------------------------------
Handelsgericht Wien
1 eingetragen am 24.08.2019 Geschäftsfall 73 Fr 7835/19 y
Antrag auf Neueintragung einer Firma eingelangt am 29.07.2019
2 eingetragen am 23.06.2020 Geschäftsfall 73 Fr 5402/20 d
Elektronische Einreichung Jahresabschluss eingelangt am 19.06.2020
4 eingetragen am 28.04.2021 Geschäftsfall 73 Fr 12166/21 i
Antrag auf Änderung eingelangt am 20.04.2021
Landesgericht Wiener Neustadt
5 eingetragen am 08.05.2021 Geschäftsfall 8 Fr 2130/21 f
Antrag auf Sitzverlegung eingelangt am 27.04.2021
-------------- INFORMATION DER ÖSTERREICHISCHEN NATIONALBANK ----------------
zum 10.05.2021 gültige Identnummer: 24513750
erstellt über Verrechnungsstelle MANZ**********************************HA021
Gerichtsgebühr: EUR 3.76******10.05.2021 10:58:32,662 41188885 ** ZEILEN: 58
Firmenbuch 10.05.2021 10:58:32
https://www.avient.com/sites/default/files/2024-02/AVNT Q4 2023 Earnings Presentation_For Website_with Non-GAAP.pdf
Microsoft PowerPoint - AVNT Q4 2023 Earnings Presentation v7
AVIENT CORPORATION
F O U R T H Q U A R T E R 2 0 2 3 R E S U L T S A N D
2 0 2 4 F I N A N C I A L G U I D A N C E
(NYSE: AVNT)
F E B R U A R Y 1 4 , 2 0 2 4
D I S C L A I M E R
Forward-Looking Statements
Certain statements contained in or incorporated by reference into this presentation constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.
ASHISH KHANDPUR
P R E S I D E N T & C E O
4
5
PORTFOLIO TRANSFORMATION
5
7%
46%
66%
87%
100%
0%
20%
40%
60%
80%
100%
2005 2010 2015 2020 2023
%
o
f A
dj
us
te
d
E
B
IT
D
A
Commodity JVs Distribution Performance Products & Solutions Specialty Businesses
Adjusted EBITDA from Specialty Applications
SUSTAINABILITY AS A GROWTH DRIVER
7
LONG-TERM REVENUE GROWTH DRIVERS
Sustainable
Solutions
Composites, Healthcare,
Asia / LATAM
Overlap
Other
60%+
Key Growth
Drivers
Total Company Revenue
Growth Drivers Long-Term Growth Rate
Sustainable Solutions 8–12%
Composites 8–10%
Healthcare 8–10%
Asia / LATAM 5%
Other 0–2%
Avient 6%
END MARKET OBSERVATIONS
( % O F C O M PA N Y S A L E S )
ENERGY
5%
DEFENSE
7%
TELECOMMUNICATIONS
4%
HEALTHCARE
7%
8
TRANSPORTATION
10%
INDUSTRIAL
16%
BUILDING &
CONSTRUCTION 9%
CONSUMER
19%
PACKAGING
23%
9
REGIONAL OBSERVATIONS
( % O F C O M PA N Y S A L E S )
9
US & Canada
Latin America
EMEA
Asia
41%
36%
18%
5%
Q 4 2 0 2 3 R E S U L T S
Q4 2023 PERFORMANCE VS.
PY
( T O TA L C O M PA N Y )
$790
$719
2022 2023
$107
$114
2022 2023
Sales Adjusted EBITDA
(in millions)
$0.42
$0.52
2022 2023
Adjusted EPS
(in millions)
- 9% + 7% + 24%
Sales Adjusted EBITDA Adjusted EPS
13
Q4 2023 SEGMENT PERFORMANCE
14
CAI
$491
$459
Sales
(in millions)
$70
$84
EBITDA
SEM
$301
$260
Sales
$55
$49
EBITDA
- 7% - 14%+20% - 11%
2022 2023
(in millions)
Q4 EBITDA BRIDGE
( T O TA L C O M PA N Y )
15
$ millions
CAI:
Price / Mix 11
Deflation 14
SEM:
Price / Mix 4
Deflation 9
Net Price Benefit 38
Cost Reductions 13
Wage Inflation (8)
Other (2)
Q4 2023 $114
Adjusted
EBITDA
Q4 2022 $ 107
Demand (34) • Demand was down, but less than in previous
quarters, due to slowing pace of destocking
• Positive net price benefit:
o CAI – Pricing flat with favorable mix from
uptick in packaging and consumer end
markets and raw material deflation
o SEM - Pricing flat with favorable mix from
Composites and raw material deflation
• Cost reductions primarily driven by reduced
administrative costs and cost synergies
2 0 2 4 G U I D A N C E
2024 GUIDANCE
Full Year 2024 Guidance
Adjusted EBITDA $505 to $535 million
Adjusted EPS $2.40 to $2.65
Interest Expense $105 to $110 million
Adjusted Effective Tax Rate 23% to 25%
Capital Expenditures ~$140 million
17
Q1 Adjusted EPS of $0.68
A P P E N D I X
20
Performance
Additives
15%
Pigments
13%
TiO2
9%
Dyestuffs
2%
Polyethylene
10%Nylon
5%
Polypropylene
4%
Styrenic Block
Copolymer
4%
Other Raw
Materials
38%
~40% hydrocarbon based
(Grey shaded materials are hydrocarbon based,
includes portion of “Other Raw Materials”)
Non-hydrocarbon
based materials
RAW MATERIAL BASKET
SEGMENT DATA
U.S. & Canada
41%
EMEA
36%
Asia
18%
Latin America
5%
2023 SEGMENT, END MARKET AND GEOGRAPHY
GEOGRAPHY REVENUESEGMENT FINANCIALS
Consumer
19%
Packaging
23%Industrial
16%
Building and
Construction
9%
Telecommunications
4%
Energy
5%
Defense
7%
END MARKET REVENUE
$2,007M $358M
$1,138M $224M
Sales EBITDA
Specialty Engineered Materials
Color Additives and Inks
$502M$3,143M
(1)
Transportation
10%
Healthcare
7%
22
(1) Total company sales and adjusted EBITDA of $3,143M and $502M, respectively, include intercompany sales eliminations and corporate costs
2 0 2 3 R E V E N U E | $ 2 . 0 B I L L I O N
US & Canada
34%
EMEA
37%
Asia
21%
Latin America
8%
END MARKET REGION
23
Packaging
34%
Consumer
21%
Healthcare
8%
Industrial
15%
Transportation
9%
Building &
Construction
10%
Telecommunications
1% Energy
2%
COLOR, ADDITIVES & INKS
2 0 2 3 R E V E N U E | $ 1 . 1 B I L L I O N
US & Canada
52%
EMEA
35%
Asia
13%
24
Packaging
5%
Consumer
16%
Healthcare
6%Industrial
16%
Transportation
12%
Telecommunications
9%
Energy
10% Defense
18%
Building &
Construction
8%
END MARKET REGION
SPECIALTY ENGINEERED MATERIALS
Packaging
32%
Consumer
26%
Healthcare
9%
Industrial
13%
Building &
Construction
6%
Telecommunications
2%
Energy
2% Defense
1%
Asia
(18% of sales)
Transportation
9%
2 0 2 3 AV I E N T R E G I O N A L S A L E S
Packaging
25%
Consumer
13%
Healthcare
5%
Industrial
18%
Building &
Construction
9%
Energy
5%
Defense
8%
EMEA
(36% of sales)Transportation
13%
Packaging
13%
Consumer
22%
Healthcare
10%
Industrial
16%
Building &
Construction
12%
Energy
6%
Defense
8%
US &
Canada
(41% of sales)
Transportation
9%
Packaging
59%
Consumer
22%
Healthcare
2%
Industrial
8%
Building &
Construction
4%
LATAM
(5% of sales)
Transportation
5%
Telecommunications
4%
Telecommunications
4%
25
B Y E N D M A R K E T
Reconciliation of Non-GAAP Financial Measures
(Unaudited)
(Dollars in millions, except for per share data)
Senior management uses comparisons of adjusted net income from continuing operations attributable to Avient shareholders
and diluted adjusted earnings per share (EPS) from continuing operations attributable to Avient shareholders, excluding special
items, to assess performance and facilitate comparability of results.
https://www.avient.com/sites/default/files/2021-09/neu-sales-terms-and-conditions.9-16-212.pdf
Buyer
must give Seller written notice of the existence of each claim
involving Product (whether based in contract, breach of
warranty, negligence, strict liability, other tort or otherwise)
within the earlier of thirty (30) days after receipt of the quantity
of Product forming the basis for the claim or applicable shelf-
life expiration, if any.
No modification or addition to the
contract shall occur by the acknowledgment or acceptance by
Seller of a purchase order, acknowledgment, release or other
form submitted by Buyer containing additional or different terms
or conditions.
19.
https://www.avient.com/sites/default/files/2024-08/Avient Thermoplastic Composite Tapes Product Overview.pdf
Available in rolls of unidirectional
tape as well as X-Ply™ 0°/90° and other multi-ply
laminates, Polystrand materials can be post-
formed and co-molded with mixed materials in
thermoforming and injection molding processes
to provide lightweight strength to a variety of part
designs.
https://www.avient.com/sites/default/files/2022-02/ColorMatrix Triple A Brochure.pdf
COLORMATRIX
TRIPLE A™
Additive technology which
reduces acetaldehyde
levels in PET packaging
TECHNICAL DESCRIPTION
Acetaldehyde (AA) forms as a result
of thermal degradation during PET
melt-processing and can increase
as temperature, pressure and shear
in processing rises.
https://www.avient.com/sites/default/files/2023-10/Nonwoven Colorants and Additives Brochure_A4.pdf
Avient offers a comprehensive portfolio of colorants and additives for nonwovens
in the form of concentrates.
https://www.avient.com/sites/default/files/2022-02/Avient Design Overview Brochure.pdf
HOW4D DESIGN PROCESSU S E O U R 4 D P R O C E S S T O A C C E L E R AT E N E W P R O D U C T D E V E L O P M E N T
SPECIALTY
PORTFOLIO
We combine design services with Avient’s
materials portfolio to bring an unbiased,
expert point of view to your design1
Color & Additives
Engineered Materials
Composites
Soft Touch
Distribution
Rely on our technical expertise to validate
that designs are manufacturable and materials
will perform as intended once formed
MANUFACTURING4 FEA/Moldflow/Mechanical SimulationDesign OptimizationDesign for Manufacturing
Processing Expertise
Supply Chain Development
Visualize color, material and finish options
using our exclusive tools and expertise3 COLOR, MATERIAL & FINISH (CMF)DESIGN Color & EffectsTexture/FinishApplication Development
Material Specification
2 INDUSTRIALDESIGN From ergonomics and concept sketches to 3D models and photo rendering, you can count on our world-class studio to help you innovate
Ethnography
Brand Language Development
Ergonomics & Usability
Concept Sketching
3D Modeling
3D Prototypes
Photo Renderings
WANT TO LEARN MORE?
https://www.avient.com/sites/default/files/2020-09/cai-healthcare-application-bulletin.pdf
COLORANTS & ADDITIVES
FOR HEALTHCARE
Essential polymer solutions
for critical healthcare applications
WHEN MATERIAL EXPERTISE IS
CRITICAL
AESTHETIC APPEAL
Regulatory compliant and
approved masterbatch colors
use custom polymer colorants
to achieve any shade
SPECIAL EFFECTS
Enhance your brand and stand
apart with pearlescent, metallic,
iridescent, fluorescent or
thermo-chromatic effects
SOLID TO LIQUID
SOLUTIONS
Choose from a full range of
available color solutions,
from liquid color to solid
product forms
ANTIMICROBIALS
Efficacy performance and
regulatory requirements are
met in a wide range of resins
compatible with Withstand™
antimicrobial technology
SURFACE ENERGY
MODIFICATION
Additive technologies such as
low retention, hydrophobic,
lubricious, light diffusion, or
anti-stat provide desired surface
manipulation
Materials used for today’s medical devices, parts and pharmaceutical packaging contribute significantly to
performance and, in turn, to a patient’s health and well-being.